NZ203700A - Multi-layer sustained release medicament delivery device - Google Patents

Multi-layer sustained release medicament delivery device

Info

Publication number
NZ203700A
NZ203700A NZ203700A NZ20370083A NZ203700A NZ 203700 A NZ203700 A NZ 203700A NZ 203700 A NZ203700 A NZ 203700A NZ 20370083 A NZ20370083 A NZ 20370083A NZ 203700 A NZ203700 A NZ 203700A
Authority
NZ
New Zealand
Prior art keywords
delivery device
sustained release
medicament delivery
release medicament
layer sustained
Prior art date
Application number
NZ203700A
Inventor
S B Mitra
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of NZ203700A publication Critical patent/NZ203700A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NZ203700A 1982-03-26 1983-03-25 Multi-layer sustained release medicament delivery device NZ203700A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/362,116 US4451260A (en) 1982-03-26 1982-03-26 Sustained release oral medicinal delivery device

Publications (1)

Publication Number Publication Date
NZ203700A true NZ203700A (en) 1985-07-31

Family

ID=23424764

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ203700A NZ203700A (en) 1982-03-26 1983-03-25 Multi-layer sustained release medicament delivery device

Country Status (7)

Country Link
US (1) US4451260A (en)
EP (1) EP0090560B1 (en)
JP (1) JPS58174312A (en)
AU (1) AU555061B2 (en)
CA (1) CA1194797A (en)
DE (1) DE3379774D1 (en)
NZ (1) NZ203700A (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
JPS58134019A (en) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd Slow-releasing triple-layered film pharmaceutical containing prostaglandin and its preparation
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4661388A (en) * 1985-01-24 1987-04-28 Minnesota Mining And Manufacturing Company Pad fragrance sampling device
DK162986A (en) * 1985-04-12 1986-10-13 Forest Laboratories THERAPEUTIC UNIT IN UNIT DOSAGE FORM
JPS6342094Y2 (en) * 1985-07-02 1988-11-04
US4712460A (en) * 1985-11-18 1987-12-15 Biotrack, Inc. Integrated drug dosage form and metering system
US4719237A (en) * 1986-01-28 1988-01-12 Merrell Dow Pharmaceuticals Inc. Cardiac antiarrythmic method employing probucol
DE3612211A1 (en) * 1986-04-11 1987-10-15 Basf Ag CONTINUOUS TABLET METHOD
DE3630603A1 (en) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh PHARMACEUTICAL AND DOSAGE FORM FOR MEDICINAL ACTIVE SUBSTANCES, REAGENTS OR THE LIKE, AND METHOD FOR THE PRODUCTION THEREOF
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (en) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts FLOATING ORAL THERAPEUTIC SYSTEM
JPH02143824U (en) * 1989-04-28 1990-12-06
US5061751A (en) * 1989-06-02 1991-10-29 Exxon Chemical Patents Inc. Vinylpyrrolidone grafted polyolefins in polymer blends and composites
JPH03163011A (en) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd Device stayed in stomach
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5965164A (en) * 1994-10-28 1999-10-12 Fuisz Technologies Ltd. Recipient-dosage delivery system
DE19837073A1 (en) * 1998-08-17 2000-03-23 Lohmann Therapie Syst Lts Foil-shaped drug carriers
AU766293B2 (en) * 1998-11-27 2003-10-16 Kanji Takada An oral formulation for gastrointestinal drug delivery
KR20020072290A (en) * 2000-01-20 2002-09-14 델시스 파머수티컬 코포레이션 Multi-step drug dosage forms
AU2001252559B2 (en) * 2000-05-02 2005-09-15 Otsuka Pharmaceutical Co., Ltd. Preparations for evaluating eliminative ability of stomach
US6767619B2 (en) * 2001-05-17 2004-07-27 Charles R. Owens Preform for manufacturing a material having a plurality of voids and method of making the same
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
GB0214013D0 (en) * 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
CN102188409A (en) * 2002-07-22 2011-09-21 莫诺索尔克斯有限公司 Packaging and dispensing of rapid dissolve dosage form
US20040018156A1 (en) * 2002-07-23 2004-01-29 Szeles Lori H Enzyme enhanced breath freshening film
US7241411B2 (en) * 2002-08-23 2007-07-10 Acupac Packaging, Inc. Thin film strips
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
TWI382850B (en) * 2005-07-25 2013-01-21 Otsuka Pharma Co Ltd An oral preparation useful for the determination of pyridine metabolism
TWI274889B (en) * 2005-10-06 2007-03-01 Elan Microelectronics Corp Resistive touch screen measurement system
DK1981465T3 (en) 2006-01-18 2016-02-01 Intec Pharma Ltd METHOD FOR PRODUCING delivery devices FOR ORAL USE OF A MEANS
WO2008081590A1 (en) * 2006-12-27 2008-07-10 Fujifilm Corporation Medical composition
RU2456981C2 (en) * 2007-03-30 2012-07-27 ЛИНТЕК Корпорейшн Oral film drug and method for preparing it
CA2721493C (en) * 2008-04-18 2017-11-28 Intec Pharma Ltd. Carbidopa/levodopa gastroretentive drug delivery
PL2378883T3 (en) * 2008-12-04 2016-06-30 Intec Pharma Ltd Zaleplon gastroretentive drug delivery system
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
ITBO20110233A1 (en) * 2011-04-29 2012-10-30 I M A Ind Macchine Automatic He S P A PROCEDURE AND EQUIPMENT FOR REALIZING A SOLID FORM OF MATERIAL
AU2013235266B2 (en) 2012-03-20 2017-10-19 Particle Dynamics International, Llc Gelling agent-based dosage form
US10228365B2 (en) 2012-08-20 2019-03-12 Otsuka Pharmaceutical Co., Ltd. Method for measuring carbohydrate metabolism ability, and composition for use in said method
RS54024B1 (en) 2012-10-12 2015-10-30 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
US9545376B2 (en) 2013-01-23 2017-01-17 Arx, Llc Production of unit dose constructs
WO2014142248A1 (en) 2013-03-15 2014-09-18 大塚製薬株式会社 Method of measuring insulin resistance with fatty acid combustion, and composition used herein
CA2951884A1 (en) 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Residence structures and related methods
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
JP7085473B2 (en) 2015-10-23 2022-06-16 リンドラ セラピューティクス， インコーポレイティド Gastric retention system for continuous release of therapeutic agents and how to use it
EP4302817A3 (en) 2015-12-08 2024-02-21 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
GB2551197B (en) * 2016-06-10 2019-03-13 Acergy France SAS Controlling the buoyancy of a mass of buoyant spheres
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
AU2017336154B2 (en) 2016-09-30 2023-11-09 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
JPS5512411B2 (en) * 1974-03-12 1980-04-02
US4136145A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
PH13712A (en) * 1975-12-15 1980-09-09 Hoffmann La Roche Novel dosage forms
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4055178A (en) * 1976-03-10 1977-10-25 Harrigan Roy Major Drug delivery device for preventing contact of undissolved drug with the stomach lining
JPS603286B2 (en) * 1977-03-03 1985-01-26 日本化薬株式会社 Constant-dissolution formulation
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet

Also Published As

Publication number Publication date
EP0090560A2 (en) 1983-10-05
JPS58174312A (en) 1983-10-13
CA1194797A (en) 1985-10-08
EP0090560B1 (en) 1989-05-03
EP0090560A3 (en) 1985-12-27
US4451260A (en) 1984-05-29
AU1283983A (en) 1983-09-29
AU555061B2 (en) 1986-09-11
DE3379774D1 (en) 1989-06-08

Similar Documents

Publication Publication Date Title
NZ203700A (en) Multi-layer sustained release medicament delivery device
GB2135880B (en) Osmotic drug delivery device
DE3373060D1 (en) Device for delivery of a drug
EP0184910A3 (en) Device for controlled release drug delivery
IL68159A0 (en) Closed drug delivery system
DE3166709D1 (en) Inhalation device for administering medicaments
GB2206047B (en) Multi-layer delivery system
ZA833521B (en) Brain specific drug delivery
PT80525A (en) Sustained release drug delivery device
SG43834A1 (en) Inhalation device for powdered medicaments
DE3369468D1 (en) Osmotic drug delivery system
GB8411259D0 (en) Medicinal agent
IL86802A0 (en) Drug delivery devices
GB2146525B (en) Drug delivery system
ZA81706B (en) Device for the administration of medicaments
GB2123693B (en) Sustained release device
DE3379862D1 (en) Osmotic drug delivery device
GB8328563D0 (en) Adhesive delivery device
AU1472383A (en) Douche delivery device
GB8332370D0 (en) Implantable drug release device
GB8332367D0 (en) Implantable drug release device
AU90061S (en) Dosage device for syringes
AU90062S (en) Dosage device for syringes
GB8315106D0 (en) Dose administering device
GB8715911D0 (en) Drug delivery device